You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Company Profile

Novartis AG in Consumer Health

Jun 2011

Price: US$525

About this Report

About this Report

Euromonitor International's report on Novartis AG delivers a detailed strategic analysis of the company's business, examining its performance in the Vitamins and Dietary Supplements market and the global economy.

Company and market share data provide a detailed look at the financial position of Novartis AG, while in-depth qualitative analysis will help you understand the brand strategy and growth prospects of Novartis AG This report examines:

  • Company share by region and sector
  • Brand portfolio
  • New product developments
  • Marketing and distribution strategies

A detailed SWOT analysis of Novartis AG provides strategic intelligence on:

  • Strengths and weaknesses
  • Category and country opportunities for growth
  • Challenges and threats from current competition and future prospects
  • Global and regional market positions

Research You Can Trust

Euromonitor International's company profile reports are written by our Vitamins and Dietary Supplements research team, a dedicated group of analysts that knows the industry inside and out.

Buy this report to inform your planning, strategy, marketing, sales and competitor intelligence functions.

Delivery:
Reports are delivered in pdf format and can be downloaded from your online account (called My Pages) immediately after purchase.

Table of Contents

Table of Contents

Scope of the Report

Scope

  • Scope of the Report

Strategic Evaluation

Key company facts

  • Strategic Evaluation

Consumer health helps to drive Novartis sales

  • Strategic Evaluation

Pharmaceuticals still dominate at Novartis

  • Strategic Evaluation

SWOT – Novartis AG

  • Strategic Evaluation

Key strategic objectives and challenges

  • Strategic Evaluation

Competitive Positioning

Proton pump inhibitors push Novartis ahead in 2009/2010

  • Competitive Positioning

Consumer health remains fragmented

  • Competitive Positioning

Digestive remedies drives growth for Novartis

  • Competitive Positioning

Strong growth in key regions

  • Competitive Positioning

Prevacid , Pantoloc Control help to drive Novartis’s sales

  • Competitive Positioning

Geographic Opportunities

Strength in most markets – weakness in China

  • Geographic Opportunities

Novartis must address Asia Pacific weakness

  • Geographic Opportunities

Consider expanding into new markets

  • Geographic Opportunities

Brazil to lead analgesics growth

  • Geographic Opportunities

Product launches drive cough, cold and allergy remedies

  • Geographic Opportunities

Focus on Benefiber in VDS

  • Geographic Opportunities

Consider launching Nicotinell into Brazilian market

  • Geographic Opportunities

Russian market holds promise

  • Geographic Opportunities

Product Opportunities

Consider Brazil and Japan for Otrivin launch

  • Product Opportunities

Consider establishing Asia Pacific production

  • Product Opportunities

Chinese preference for topical analgesics boosts Voltaren

  • Product Opportunities

China offers best potential for topical antifungals

  • Product Opportunities

Brand and Private Label Strategy

Exceptionally strong brand portfolio

  • Brand and Private Label Strategy

Voltaren benefits from extensions and ageing population

  • Brand and Private Label Strategy

Operations

Research and d evelopment , production and distribution

  • Operations

Recommendations

Key recommendations

  • Recommendations

Samples

Please update/install flash.

my pages

Want to find out more about this report?

If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!